AI Biotech Enterprise Valence Labs operates as Recursion’s AI research engine within biotechnology, indicating high potential for advanced AI/ML collaboration, platform integrations, and bespoke predictive modeling services for pharma and biotech customers.

Growing Team With 11-50 employees, Valence Labs is a lean, fast-moving unit likely looking for scalable tools, developer-friendly APIs, and cost-effective software to accelerate research, enabling sales reps to pitch modular, low-friction solutions.

Revenue Range Current revenue of 1M–10M signals a validated business with growth runway; opportunities exist to upsell experimentation platforms, data infrastructure, or expanded AI capabilities to support scale and global collaborations.

Biotech AI Focus As an AI-driven research engine in biotechnology, there is strong alignment for selling data platforms, cloud compute credits, model explainability tools, and security/compliance features tailored to life sciences.

Part of Recursion Ecosystem Leveraging Recursion’s platform and infrastructure suggests strategic partnerships around integration, co-development, and enterprise-level partnerships that extend Recursion’s ecosystem into Valence Labs’ client and research networks.